Praxis Precision Medicines (PRAX) Retained Earnings (2022 - 2025)
Historic Retained Earnings for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to -$1.1 billion.
- Praxis Precision Medicines' Retained Earnings fell 4137.0% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 4137.0%. This contributed to the annual value of -$836.7 million for FY2024, which is 2795.74% down from last year.
- Latest data reveals that Praxis Precision Medicines reported Retained Earnings of -$1.1 billion as of Q3 2025, which was down 4137.0% from -$977.2 million recorded in Q2 2025.
- Praxis Precision Medicines' Retained Earnings' 5-year high stood at -$385.3 million during Q1 2022, with a 5-year trough of -$1.1 billion in Q3 2025.
- Its 4-year average for Retained Earnings is -$688.0 million, with a median of -$653.9 million in 2023.
- As far as peak fluctuations go, Praxis Precision Medicines' Retained Earnings plummeted by 4743.13% in 2023, and later tumbled by 2054.89% in 2024.
- Over the past 4 years, Praxis Precision Medicines' Retained Earnings (Quarter) stood at -$530.6 million in 2022, then dropped by 23.23% to -$653.9 million in 2023, then decreased by 27.96% to -$836.7 million in 2024, then tumbled by 31.46% to -$1.1 billion in 2025.
- Its Retained Earnings stands at -$1.1 billion for Q3 2025, versus -$977.2 million for Q2 2025 and -$906.0 million for Q1 2025.